Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience.
Yago
Y
González Lama
Luis E
LE
Abreu
Maria I
MI
Vera
Juan
J
de la Revilla
Natalia
N
Fernandez-Puga
Pedro
P
Escartin
D000284:Administration, Oral; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D004351:Drug Resistance; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007412:Intestinal Fistula / Q000209:etiology*; D019233:Retreatment; D016559:Tacrolimus / Q000008:administration & dosage*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab; D016559:Tacrolimus